PURE Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
PURE Bioscience, Inc. (PURE) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $64.50 million as of 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2023-10-30
- 2023-07-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $64.50M.
- 2022-07-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $63.30M.
- 2021-07-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $62.30M.
- 2020-07-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $61.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2023-07-31 | $64.50M 10-K · filed 2023-10-30 |
| 2022-07-31 | $63.30M 10-K · filed 2022-10-28 |
| 2021-07-31 | $62.30M 10-K · filed 2021-10-28 |
| 2020-07-31 | $61.80M 10-K · filed 2021-10-28 |
| 2019-07-31 | $62.10M 10-K · filed 2020-10-08 |
| 2018-07-31 | $60.50M 10-K · filed 2019-10-30 |
| 2017-07-31 | $74.70M 10-K · filed 2018-10-25 |
| 2016-07-31 | $79.00M 10-K · filed 2017-10-26 |
| 2015-07-31 | $77.50M 10-K · filed 2016-10-27 |